While ITE-bound AhRs bind to many other target genes besides POU5F1 and its anticancer effects certainly cannot be solely attributed to Oct4 suppression, our results demonstrated that the AhR-mediated Oct4-suppressing effect of ITE contributed significantly to inhibiting the formation and propagation of stem-like cancer cells. The gene discussed is AHR; the disease is cancer.